Identification of a new methylation site in the Sept9 promoter region for the diagnosis of hepatocellular carcinoma
Background. Over 600,000 people die from hepatocellular carcinoma (HCC) each year worldwide. The disease is often detected at advanced stages and in many cases is not curable. Early diagnostic and monitoring of HCC recurrences remains a substantial problem in clinical oncology. That determines the n...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-12-01
|
Series: | Uspehi Molekulârnoj Onkologii |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/239 |